Answer: egocentric thought
Explanation:
he is only thinking of his self
Answer:
The correct answer is The cells do not have proper receptor.
Explanation:
During paracrine signaling a signaling molecules are generated from one cell.The generated signaling molecule then binds to the receptor of neighboring cell to carry specific signal from donor cell to the acceptor cell.
But the signaling molecules will not bind to the cell that is producing it because that producing cell do not contain proper receptor to bind that signaling molecule.
The binding of signaling molecule to the receptor of its producing cell occur during autocrine signaling.
Answer:
The correct answer is option E. "nucleotides can only be added to an available 3'-OH group on the transcript terminus".
Explanation:
RNA synthesis is catalyzed by an enzyme called RNA polymerase. RNA polymerase always catalyze the synthesis of new RNA from 5' to 3' because nucleotides can only be added to an available 3'-OH group on the transcript terminus. This has been confirmed in labeling experiments with γ-32P substrates which establish the presence of a triphosphate moiety in transcripts with either pppG or pppA.
Because their bodies tell them that they need more oxygen and so breathe faster, and try and get the oxygen their body requires and depends on.
Answer:
Thermosensitive liposomes (TSL) are promising tools used to deliver drugs to targeted region when local hyperthermia is applied (∼40–42°C) which triggers the membrane phase transformation from a solid gel-like state to a highly permeable liquid state. Selective lipid components have been used to in TSL formulations to increase plasma stability before hyperthermia and speed drug release rate after. Two generations of TSL technology have been developed. The traditional thermal sensitive liposomes (TTSL) have utilized DPPC and DSPC as a combination. The second generation, lysolipid thermally sensitive liposomes (LTSL) technology, has been developed with incorporation of lysolipids that form stabilized defects at phase transition temperature. LTSL maintains certain favorable attributes:
High percentage of lysolipids incorporation;
Minimum leakage for therapeutical drugs encapsulation;
Ultrafast drug release upon heating (3.5 times enhanced compared to TTSL). For example, ThermoDox, a commonly used LTSL drug for cancer, has been reported to release 100% of the encapsulated doxorubicin within 30s;
First and most successful formulation for intravascular drug release.
Explanation:
https://www.creative-biostructure.com/Lysolipid-Thermally-Sensitive-Liposomes-Production-612.htm
